본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

Safety Evaluation of Sankhaholi (Evolvulus alsinoides Linn.) in the Management of Essential Hypertension: A Randomized Standard Control Trial

이용수 0

영문명
발행기관
셀메드 세포교정의약학회
저자명
Qamar Alam Khan Asim Ali Khan Shagufta Parveen
간행물 정보
『셀메드』Volume 9 Issue 4, 1~4쪽, 전체 4쪽
주제분류
의약학 > 의학일반
파일형태
PDF
발행일자
2019.11.29
무료

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Background: Hypertension is one of the major risk factors for stroke, heart attack, heart failure and kidney failure, thereby causing deaths and disability world-wide. The most predominant type of HTN is essential hypertension (HTN). Unani scholars have mentioned about the clinical manifestations and management of the hypertension and documented it in the context of ‘Imtila’. The drug Sankhaholi (Evolvulus alsinoides Linn.) is one of the widely prescribed medicines for the management of essential hypertension in Unani medicine. Material and Methods: The present clinical study was carried out to evaluate the safety of Sankhaholi (Evolvulus alsinoides Linn.) in the management of stage-1 essential hypertension. Newly diagnosed 41 patients of Essential Hypertension (22 patients were in the test group and 19 patients in the control group) were enrolled for the study. All the patients in the test group were given with the test drug 3 g powder of Sankhaholi twice a day for 6 weeks orally. Patients in the control group were given standard drug Ramipril 5 mg once a day for the same duration. Clinical as well as hematological parameters were recorded before and after the treatment. Results: No significant changes are recorded in safety parameters viz. CBC, Haemogram, LFT and KFT. Clinically no adverse effect of the drug has been reported during the course of treatment. Also, significant effect on the systolic blood pressure (p<0.001) were recorded in test group. The drug Sankhaholi was also found effective on the symptoms associated with hypertension. Conclusion: The finding of the study revealed that the test drug Sankhaholi (Evolvulus alsinoides Linn.) is safe and has substantial efficacy as an antihypertensive drug.

목차

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Qamar Alam Khan,Asim Ali Khan,Shagufta Parveen. (2019).Safety Evaluation of Sankhaholi (Evolvulus alsinoides Linn.) in the Management of Essential Hypertension: A Randomized Standard Control Trial. 셀메드, 9 (4), 1-4

MLA

Qamar Alam Khan,Asim Ali Khan,Shagufta Parveen. "Safety Evaluation of Sankhaholi (Evolvulus alsinoides Linn.) in the Management of Essential Hypertension: A Randomized Standard Control Trial." 셀메드, 9.4(2019): 1-4

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제